Globeimmune Inc
OTC:GBIM
Income Statement
Earnings Waterfall
Globeimmune Inc
Revenue
|
6.2m
USD
|
Cost of Revenue
|
-127.2k
USD
|
Gross Profit
|
6.1m
USD
|
Operating Expenses
|
-8.2m
USD
|
Operating Income
|
-2.1m
USD
|
Other Expenses
|
0
USD
|
Net Income
|
-2.1m
USD
|
Income Statement
Globeimmune Inc
Jun-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||
Revenue |
6
N/A
|
5
-9%
|
6
+23%
|
9
+37%
|
23
+159%
|
22
-3%
|
19
-11%
|
18
-5%
|
6
-67%
|
6
-4%
|
5
-8%
|
7
+31%
|
6
-7%
|
6
-4%
|
|
Gross Profit | |||||||||||||||
Cost of Revenue |
0
|
0
|
(2)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
3
N/A
|
5
+79%
|
19
+322%
|
19
+0%
|
18
-7%
|
17
-6%
|
4
-74%
|
4
-6%
|
4
+0%
|
6
+46%
|
6
+1%
|
6
-1%
|
|
Operating Income | |||||||||||||||
Operating Expenses |
(9)
|
(9)
|
(6)
|
(9)
|
(12)
|
(11)
|
(11)
|
(11)
|
(10)
|
(15)
|
(15)
|
(10)
|
(9)
|
(8)
|
|
Selling, General & Administrative |
(2)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
|
Research & Development |
(6)
|
(6)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Operating Expenses |
0
|
0
|
(1)
|
(2)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(8)
|
(8)
|
(3)
|
(2)
|
(2)
|
|
Operating Income |
(3)
N/A
|
(3)
-14%
|
(1)
+57%
|
(3)
-87%
|
8
N/A
|
9
+11%
|
7
-23%
|
6
-4%
|
(6)
N/A
|
(11)
-87%
|
(11)
+0%
|
(4)
+66%
|
(3)
+25%
|
(2)
+25%
|
|
Pre-Tax Income | |||||||||||||||
Interest Income Expense |
0
|
0
|
1
|
1
|
2
|
0
|
(5)
|
(5)
|
(6)
|
(5)
|
(0)
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(3)
N/A
|
(3)
+21%
|
(0)
+82%
|
(1)
-151%
|
10
N/A
|
9
-9%
|
2
-78%
|
(4)
N/A
|
(16)
-335%
|
(15)
+5%
|
(11)
+29%
|
(4)
+66%
|
(3)
+25%
|
(2)
+25%
|
|
Net Income | |||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(3)
|
(3)
|
(0)
|
(1)
|
9
|
9
|
2
|
(4)
|
(16)
|
(15)
|
(11)
|
(4)
|
(3)
|
(2)
|
|
Net Income (Common) |
(9)
N/A
|
(9)
+5%
|
(7)
+22%
|
(11)
-57%
|
(3)
+69%
|
(5)
-33%
|
(12)
-155%
|
(14)
-24%
|
(23)
-64%
|
(19)
+18%
|
(11)
+41%
|
(4)
+67%
|
(3)
+25%
|
(2)
+25%
|
|
EPS (Diluted) |
-1.82
N/A
|
-1.72
+5%
|
-1.35
+22%
|
-2.11
-56%
|
-0.66
+69%
|
-0.88
-33%
|
-2.24
-155%
|
-2.53
-13%
|
-8.04
-218%
|
-3.32
+59%
|
-1.98
+40%
|
-0.53
+73%
|
-0.48
+9%
|
-0.35
+27%
|